ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3002

The Regulatory Role of Gammadelta T Cells in Bleomycin-Induced Pulmonary Fibrosis

Seiji Segawa1, Daisuke Goto2, Akira Iizuka3, Masahiro Yokosawa3, Shunta Kaneko3, Yuya Kondo3, Isao Matsumoto3 and Takayuki Sumida3, 1Division of Clinical Immunology, Doctoral Program in Clinical Sciences,, University of Tsukuba, Tsukuba, Japan, 2Division of Clinical Immunology, Doctoral Program in Clinical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan, 3Department of Internal Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: pulmonary fibrosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 10, 2015

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's - Pathogenesis, Animal Models and Genetics Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Interstitial pneumonia (IP) is a chronic progressive interstitial lung disease associated with high mortality and poor prognosis. However, the exact mechanism of IP remains elusive. Recently, the pathological role of gdT cells was reported in several IP mice models. The γδT cells could produce a wide variety of cytokines, chemokines and growth factors and these cells have an important role in the regulation of the initial immune responses. In human, we previously reported that γδT cells might concern the pathogenesis of IP in systemic sclerosis patients. However, there are no reports on the properties and functional characteristics of γδT cells in pulmonary fibrosis. The purpose of this study is to clarify the role of γδT cells in bleomycin-induced IP model mice.

Methods: 1.C57BL/6 (WT) mice were injected with bleomycin (1.25mg/kg, intratracheally). After 3, 7, 14 and 21 days, the phenotypes of pulmonary γδT cells were examined by flow cytometry (FCM). 2.WT and TCRδ deficient (TCRδ-/-) mice were injected with bleomycin and the pathological findings were examined. 3.WT and TCRδ-/- mice were injected with bleomycin. At 3, 7, 14, 21 days, pulmonary Th17 (IL-17A+ CD4+ T) and Treg (Foxp3+ CD4+) cells were analyzed by FCM. 4.Splenic CD4+T cells isolated from WT mice were co-cultured with γδT cells in condition of Th17 cell differentiation.

Results: 1.The number of pulmonary γδT cells increased at day3, 7, 14 after bleomycin exposure (p<0.05, p<0.05 and p<0.05, respectively). At 3 days after bleomycin exposure, pulmonary IFN-γ+ γδT cells increased (p<0.05). On the other hands, pulmonary IL-17A+ γδT cells increased at 7, 14 and 21 days after bleomycin exposure (p<0.05, p<0.05 and p<0.05, respectively). 2.TCRδ-/- mice showed pronounced hypercellularity and intimal thickening in lung parenchyma, and overproduction of collagen in lungs compared with WT mice. 3.In TCRδ-/- mice, pulmonary IL-17A+ CD4+ T cells increased at day 7 and 14 after bleomycin exposure compared with WT mice (p<0.05 and p<0.05, respectively). Pulmonary Foxp3+ CD4+ T cells were not significantly difference between WT and TCRδ-/- mice. 4.After co-cultured with γδT cells, the rate of IL-17A production in CD4+ T cells and the number of IL-17A+ CD4+T cells were significantly decreased (p<0.05 and p<0.05, respectively).

Conclusion: Pulmonary γδT cells might play a regulatory role in the generation of bleomycin induced IP model mice via the suppression of IL-17 production.


Disclosure: S. Segawa, None; D. Goto, None; A. Iizuka, None; M. Yokosawa, None; S. Kaneko, None; Y. Kondo, None; I. Matsumoto, None; T. Sumida, None.

To cite this abstract in AMA style:

Segawa S, Goto D, Iizuka A, Yokosawa M, Kaneko S, Kondo Y, Matsumoto I, Sumida T. The Regulatory Role of Gammadelta T Cells in Bleomycin-Induced Pulmonary Fibrosis [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/the-regulatory-role-of-gammadelta-t-cells-in-bleomycin-induced-pulmonary-fibrosis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-regulatory-role-of-gammadelta-t-cells-in-bleomycin-induced-pulmonary-fibrosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology